1. Nilesh K., Vande A. V.: Mucormycosis of maxilla following tooth extraction in immunocompetent patients: reports and review. J Clin Exp Dent. 2018; 10 (3): e300.
2. Paultauf A.: Mycosis mucorina. Ein Beitrag zur Kenntniss der menschlichen Fadenpilzerkrankungen. Arch Path Anat. 1885, 102 (3): 543–564.
3. Cornely O. A., Alastruey-Izquierdo A., Arenz D., et al.: Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet Infect Dis. 2019; 19 (12): e405–e421.
4. Sikora M., Małecka M., Stąpor A., et al.: Mucormycosis of the maxillary sinus in an immunocompetent woman with oro-antral fistula — a case report. Pomeranian Journal of Life Sciences. 2021; 67 (1): 32– 37.
5. Rawlani S.S., Siddiqui A., Reza M., et al.: Black Fungus Mucormycosis, Epidemiology, Etiopathogenesis, Clinical Diagnosis, Histopathology and its Management — A Review. Int J Med Dent Res. 2021; 1 (2): 01–08.
6. Serris A., Danion F., Lanternier F.: Disease entities in mucormycosis. Journal of Fungi. 2019; 5 (1): 23.
7. Ahmadikia K., Hashemi S.J., Khodavaisy S., et al.: The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021; 64 (8): 798–808.
8. Prakash H., Chakrabarti A.: Global epidemiology of mucormycosis. Journal of Fungi. 2019; 5 (1): 26.
9. Jeyaraj P.: Sino-Maxillary Mucormycosis of Iatrogenic Etiology in an Immunocompetent Patient- Importance of Early Diagnosis and Prompt Management. Journal of Infectious Diseases & Case Reports. 2021; 2 (1): 1–8. https://doi.org/10.47363/JIDSCR/2021.
10. Kiralj A., Nalić B., Brajković D.: Management of fulminant mucormycosis of maxillary sinus and orbit with uncontrolled diabetic. Srpski arhiv za celokupno lekarstvo. 2021; 149 (3–4): 225–228. https://doi.org/10.2298/SARH200604015K.
11. Viterbo S., Fasolis M., Garzino-Demo P., et al.: Management and outcomes of three cases of rhinocerebral mucormycosis. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endod. 2011; 112 (6): e69–e74.
12. Martínez-Herrera E., Julián-Castrejón A., Frías-De-León M.G., et al.: Rhinocerebral mucormycosis to the rise? The impact of the worldwide diabetes epidemic. Anais Brasileiros de Dermatologia. 2021; 96: 196–199.
13. Bansal D., Pandey A.K., Bhardwaj A., et al.: Extra-Rhino Cerebral Manifestations of Mucormycosis in Head and Neck Region: An Insight. Indian Journal of Otolaryngology and Head & Neck Surgery. 2021; 1–6. https://doi.org/10.1007/s12070-021-02440-z.
14. Honavar S.G.: Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito- Cerebral Mucormycosis in the Setting of COVID-19. Indian Journal of Ophthalmology. 2021; 69 (6): 1361–1365. https://doi.org/10.4103/ijo.IJO_1165_21.
15. Prabhu S., Alqahtani M., Al Shehabi M.: A fatal case of rhinocerebral mucormycosis of the jaw after dental extractions and review of literature. Journal of Infection and Public Health. 2018; 11 (3): 301–303.
16. Karthik S., Shanmugam A., Dhinakaran E.C., et al.: Mucormycosis. Case report and literature review. Hel Arch Oral & Max Fac Surg. 2021; 21 (1): 37–41.
17. Srivastava A., Mohpatra M., Mahapatra A.: Maxillary fungal osteomyelitis: A review of literature and report of a rare case. Annals of Maxillofacial Surgery. 2019; 9 (1): 168.
18. Ketenci İ, Ünlü Y., Kaya, et al.: Rhinocerebral mucormycosis: Experience in 14 patients. The Journal of Laryngology & Otology. 2011; 125 (8): E3. doi: 10.1017/S0022215111000843.
19. Prakash H., Chakrabarti A.: Epidemiology of Mucormycosis in India. Microorganisms. 2021; 9: 523.
20. Nishanth D.G., Anitha D.N., Babu D.N.A., et al.: Mucormycosis — A Review. European Journal of Molecular & Clinical Medicine. 2020; 7 (3): 1786–1791.
21. Suganya R., Malathi N., Karthikeyan V., et al.: Mucormycosis: a brief review. J Pure Appl Microbiol. 2019; 13 (1): 161–165.
22. Maini A., Tomar G., Khanna D., et al.: Sino-orbital mucormycosis in a COVID-19 patient: A case report. Int J Surg Case Rep. 2021; 82: 105957.
23. Pandiar D., Kumar N.S., Anand R., et al.: Does COVID 19 generate a milieu for propagation of mucormycosis? Med Hypotheses. 2021 Jul; 152: 110613. doi: 10.1016/j.mehy.2021.110613. PMID: 34087613; PMCID: PMC8152198.
24. Doni B.R., Peerapur B.V., Thotappa L.H., et al.: Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian J Dent Res. 2011; 22 (2): 331.
25. Fouad Y.A., Abdelaziz T.T., Askoura A., et al.: Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic. Front Med (Lausanne). 2021; 8: 645270. Published 2021 May 28. doi: 10.3389/fmed.2021.645270.
26. Banerjee M., Pal R., Bhadada S.K.: Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgrad Med J. 2021 Jun 8. doi: 10.1136/postgradmedj-2021-140537. Epub ahead of print. PMID: 34103372.
27. Reddy S.G., Kumar K.K., Sekhar C.P., et al.: Oral Mucormycosis: Need for early diagnosis! J NTR Univ Health Sci. 2014; 3: 145–147.
28. Dadhich A., Nilesh K., Patil R., et al.: Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Reports CP. 2021; 14 (1): e239199.
29. Godinho G., Abreu I., Alves G., et al.: Orbital Apex Syndrome due to Orbital Mucormycosis after Teeth Infection: A Successful Case Report. Case Reports in Ophthalmology. 2021; 12 (1): 110–115.
30. Nicolatou-Galitis O., Sachanas S., Drogari-Apiranthitou M., et al.: Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case report and literature review. JMM Case Reports. 2015; 2 (1): e000014.
31. Lupoi D., Preda M.: Fungal rhinosinusitis between regular infection and aggressive life-threatening disease. Journal of Contemporary Clinical Practice. 2020; 6 (2): 86–92.
32. Santosh A.B.R., Muddana K., Bakki S.R.: Fungal infections of oral cavity: diagnosis, management, and association with COVID-19. SN Compr Clin Med. 2021; 3: 1373–1384.
33. Bonifaz A., Tirado-Sánchez A., Paredes-Farrera F., et al.: Oral involvement in mucormycosis. A retrospective study of 55 cases. Enferm Infecc y Microbiol Clín. (English ed.) 2020. S0213-005X (20) 30293-7.
34. Gupta D.K., Gupta D.K., Gupta N.: Dental Complications After Covid-19 Mucormycosis?? Under-standing The Pathophysiology. Guident. 2021 Mar; 14 (4): 26–29.
35. Kwak E.J., Kim D.J., Nam W., Park W.: Mucormycosis in the Jaw: A Report of 2 Cases and Literature Review. Oral Health & Preventive Dentistry. 2020; 18 (1): 1011–1016. https://doi.org/10.3290/j.ohpd.a45522.
36. Brunet K., Rammaert B.: Mucormycosis treatment: Recommendations, latest advances, and perspectives. J Mycol Méd. 2020; 30 (3): 101007.
37. Panneerselvam K., Kumar M.S., Karthikeyan A.: Recurrent mucormycosis — Better understanding of treatment and management. J Family Med Prim Care. 2020; 9 (12): 6279.
38. Gaur V., Patel K., Pałka Ł.: An implant-supported prosthetic rehabilitation of a patient with a bilateral subtotal maxillectomy defect secondary to rhino-orbital-cerebral mucormycosis: A clinical report of a graftless approach. J Prosthet Dent. 2021 Feb 4: S0022-3913(21)00005-6. doi: 10.1016/j.prosdent.2020.12.022.Epub ahead of print. PMID: 33551135.